Dermapharm Holding SE

Dermapharm Holding SE

Verified
Offers dermatological, skin care, and allergy medicines

Launch date
Employees
Ownership
Market cap
€2.7b
Net debt
€893m
Firm valuation
$4.1b (Public information from 2022)
Hünenberg Canton of Zug (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-467m572m701m794m947m1.1b
% growth--22 %23 %13 %19 %15 %
EBITDA-113m143m178m201m342m397m
% EBITDA margin-24 %25 %25 %25 %36 %36 %
Profit-20m75m77m85m199m231m
% profit margin-4 %13 %11 %11 %21 %21 %
EV / revenue--2.3x3.7x4.5x4.0x3.4x
EV / EBITDA--9.2x14.7x17.7x11.2x9.4x
  • Edit
DateInvestorsAmountRound
N/A€328m
Valuation: €1.5b
IPO
Total Funding-

Recent News about Dermapharm Holding SE

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Dermapharm Holding SE

Edit
Cannabinoid Compound Company
ACQUISITION by Dermapharm Holding SE Dec 2021